Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Greenwich LifeSciences (GLSI) Equity Ratio (2019 - 2025)

Greenwich LifeSciences filings provide 7 years of Equity Ratio readings, the most recent being 0.57 for Q3 2025.

  • Quarterly Equity Ratio fell 32.9% to 0.57 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.57 through Sep 2025, down 32.9% year-over-year, with the annual reading at 0.62 for FY2024, 35.38% down from the prior year.
  • Equity Ratio hit 0.57 in Q3 2025 for Greenwich LifeSciences, up from 0.46 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.99 in Q1 2022 and bottomed at 0.46 in Q2 2025.
  • Average Equity Ratio over 5 years is 0.87, with a median of 0.97 recorded in 2023.
  • The largest annual shift saw Equity Ratio skyrocketed 32.57% in 2021 before it tumbled 48.66% in 2025.
  • Greenwich LifeSciences' Equity Ratio stood at 0.99 in 2021, then decreased by 0.54% to 0.98 in 2022, then dropped by 2.3% to 0.96 in 2023, then tumbled by 35.38% to 0.62 in 2024, then dropped by 7.28% to 0.57 in 2025.
  • Per Business Quant, the three most recent readings for GLSI's Equity Ratio are 0.57 (Q3 2025), 0.46 (Q2 2025), and 0.48 (Q1 2025).